Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ensysce Biosciences Inc.

1.76
-0.1200-6.38%
Post-market: 1.790.0300+1.70%19:55 EDT
Volume:133.33K
Turnover:233.60K
Market Cap:2.89M
PE:-0.15
High:1.82
Open:1.80
Low:1.71
Close:1.88
Loading ...
May 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2024

Major Issues Report

Form 8-K - Current report
Apr 03, 2024

Correspondence

Form CORRESP - Correspondence
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 26, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 15, 2024

Major Issues Report

Form 8-K - Current report
Mar 15, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Jan 17, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 29, 2023

Major Issues Report

Form 8-K - Current report
Dec 20, 2023

Major Issues Report

Form 8-K - Current report
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 21, 2023

Correspondence

Form CORRESP - Correspondence
Nov 18, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 18, 2023

Major Issues Report

Form 8-K - Current report
Nov 10, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Nov 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Oct 24, 2023

Major Issues Report

Form 8-K - Current report